Clinical Trials Browser

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

NCT04566393 2026-01-28

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Clinical Trials

An Intermediate Expanded Use Trial of DFMO

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

Expanded Access [11C] Methionine PET Imaging

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

18F-Floretyrosine Expanded Access Program

Expanded Access Program for GBM Subjects

131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma

Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered

Vorasidenib Expanded Access Program

Expanded Access Program for Avapritinib

TVI-Brain-1 in Expanded Access Patient

Expanded Access Program (EAP) for Tovorafenib (DAY101) in RAF-Altered, Relapsed or Refractory Low-Grade Glioma

Treatment of Recurrent GBM With APG-157 Via Expanded Access

TRIANGLE

A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma

Expanded Access for KHK2455

Individual Patient Compassionate Use of Mirdametinib

Glioblastoma and Individualized Therapies

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Expanded Access Protocol Using 131I-MIBG

EAP for the Treatment of Glioblastoma With PVSRIPO

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

Individual Patient Compassionate Use of GX-I7

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Expanded Access for Pembrolizumab (MK-3475)

CDX-110

Expanded Access to ANG1005 for Individual Patients

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma